Please use this identifier to cite or link to this item:
Title: Falsified medicines directive : challenges faced by small member states
Authors: Almojero, Danielle Claire E.
Vella Szijj, Janis
Serracino-Inglott, Anthony
Keywords: Drugs -- Law and legislation -- European Union countries
Drugs -- Law and legislation -- Malta
Pharmaceutical industry -- Malta
Drug adulteration -- Law and legislation -- Malta
Issue Date: 2020
Publisher: University of Malta. Department of Pharmacy
Citation: Almojero, D. C. E., Vella Szijj, J., & Serracino-Inglott, A. (2020). Falsified medicines directive : challenges faced by small member states. FIP Virtual Event : Living and Learning Through the Covid-19 Pandemic - Global Reflections.
Abstract: Falsified medicines can be considered substandard in quality, formulation, labelling and/or without appropriate registration with the competent authority. The Falsified Medicines Directive (FMD) or Directive 2011/62/EU, which amended Directive 2001/83/EC, was implemented in February 2019 to decrease the use of falsified medicines.
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Almojero - Falsified Medicines Directive_ Challenges Faced by Small Member States.pdf291.35 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.